While GHK-Cu is generally well-tolerated in topical research, certain contraindications or precautions should be considered, especially for systemic research or in specific populations: Systemic Research: For systemic applications, GHK-Cu is generally not recommended for subjects who are pregnant, breastfeeding, have active cancer, or suffer from Wilsons disease (a condition involving copper accumulation)
What Sex-Specific Risks Mean for a GLP-1 Treatment Plan Its good to have an awareness of sex-specific risks, but the impact of a GLP-1 is still mostly based on the individual and their specific health conditions
Sinagra E, Pompei G, Tomasello G, Cappello F, Morreale GC, Amvrosiadis G, et al
Teduglutide (Gattex) is the FDA-approved GLP-2 receptor agonist, indicated for short bowel syndrome a niche gastrointestinal condition